Vision Loss and Blindness Resources

  Main Menu


  Our Other Sites
Research & Clinical Studies #11-20

  1. An evaluation of safety and efficacy of Anecortave Acetate versus placebo in patients with subfoveal CNV due to exudative AMD.
    Conditions: Macular Degeneration; Maculopathy, Age-Related

  2. An evaluation of safety and efficacy of Anecortave Acetate vs. placebo in patients with subfoveal choroidal neovascularization(CNV) due to wet age-related macular degeneration(AMD)
    Conditions: Macular Degeneration; Maculopathy, Age-Related; Age-Related Maculopathies; Age-Related Maculopathy; Maculopathies, Age-Related

  3. Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors
    Condition: childhood cancer

  4. Biological Markers in Retinal Vasculitis
    Condition: Retinal Vasculitis

  5. Blood Factors and Diabetic Retinopathy
    Condition: Diabetic Retinopathy

  6. BMS-247550 to Treat Children with Solid Tumors
    Conditions: Neoplasms; Neoplasm by Histologic Type; Optic Glioma; Brainstem Tumor

  7. Brain Plasticity of Verbal Memory in the Blind
    Condition: Blindness

  8. Celecoxib to Treat Macular Degeneration in Patients Receiving Photodynamic Therapy
    Condition: Macular Degeneration

  9. Chemotherapy and Stem Cell Transplantation in Treating Children with Central Nervous System Cancer
    Conditions: central nervous system cancer; childhood brain tumor; hematopoietic and lymphoid cancer; Neuroblastoma; Retinoblastoma

  10. Clinical and Basic Investigations into Hermansky-Pudlak Syndrome
    Conditions: Albinism; Intestinal Disease; Kidney Disease; Myocardial Disease; Pulmonary Fibrosis
01-10 11-20 21-30 31-40 41-50 51-60 61-70 71-80 81-90 91-97


   Source: ClinicalTrials.gov
All brands and product names are trademarked or registered trademarks of their respective companies.
Copyright of syndicated content belongs to it’s respective author or news organization.
Original content (including "look and feel") Copyright © 2001-2006  •  Vision Loss and Blindness Resources  •  All rights reserved.